Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71335-2973

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71335-2973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (E887abe7 4443 4b77 8e84 4c7cc0098e94 01)

Chemical structure of Ondansetron, depicting its molecular framework with distinct aromatic rings and functional groups as shown in the diagram.*

FDA Label Image

Label (Lbl713352973)

Ondansetron ODT 8 mg orally disintegrating tablet label showing the product name, strength, NDC 71335-2973-1, and quantity of 90 tablets. The label includes storage instructions (20° to 25° C, excursions permitted 15° to 30° C), manufacturer Ipca Laboratories Limited, and repackager Bryant Ranch Prepack, Inc. Barcodes and QR codes are present for tracking and package insert access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.